At 10.9% CAGR, Europe Aesthetic Medical Devices Market is Projected to be Worth US$ 13,739.86 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe aesthetic medical devices market was valued at US$ 6,010.73 million in 2023 and is expected to reach US$ 13,739.86 million by 2031, registering a CAGR of 10.9% from 2023 to 2031. Rising spending on medical and technological advancements associated with medical aesthetic devices are among the critical factors attributed to drive the Europe aesthetic medical devices market growth.

Rapid urbanization, increasing investments by healthcare providers in improving infrastructure, growing awareness among the population, and the availability of a wide range of advanced products and technologies have contributed to making them the centers of medical tourism. In Russia healthcare systems focus on introducing various advanced medical aesthetic technologies into their service portfolios. Patients from developed regions travel to emerging countries for various medical aesthetic procedures. Health facilities, medical spas, and wellness centers increasingly offer a comprehensive range of inexpensive but high-quality medical aesthetic procedures. The spending on cosmetic and rejuvenation procedures to improve aesthetics is rapidly increasing among the global population. There is rising awareness about minimally invasive treatments and acceptance of aesthetic procedures in the population, growing need for an ideal physical appearance, increasing incidence of skin diseases, growing geriatric population, and rising availability and acceptance of technologically advanced medical devices. Also, surging healthcare spending enables healthcare professionals to adopt advanced technologies for performing cosmetic procedures. Thus, rising spending on medical procedures in developing countries is expected to create growth opportunities for the aesthetic medical devices market during the forecast period.

On the contrary, risks and complications associated with procedures and stringent safety regulations hurdle the growth of Europe aesthetic medical devices market.

Based on technology, the Europe aesthetic medical devices market is divided into laser-based, light-based, electromagnetic energy-based, ultrasound-based, cryolipolysis, suction-based, and plasma energy-based. The laser-based segment held 24.4% market share in 2023, amassing US$ 1,467.28 million. It is projected to garner US$ 3,424.31 million by 2031 to register 11.2% CAGR during 2023–2031.

In terms of application, the Europe aesthetic medical devices market is segmented into facial skin resurfacing, photorejuvenation, hair removal, fat reduction and body contouring, skin tightening, cellulite reduction, feminine rejuvenation, tattoos and pigmentation, acne and acne scars, vascular lesions, and others. The acne and acne scars segment held 18.9% share of Europe aesthetic medical devices market in 2023, amassing US$ 1,133.35 million. It is anticipated to garner US$ 2,491.26 million by 2031 to expand at 10.3% CAGR during 2023–2031.

By end user, the Europe aesthetic medical devices market is divided dermatology and cosmetic clinics, hospitals and clinics, medical spas, and home use. The dermatology and cosmetic clinics segment held 36.8% share of Europe aesthetic medical devices market in 2023, amassing US$ 2,212.35 million. It is projected to garner US$ 5,220.83 million by 2031 to expand at 11.3% CAGR from 2023 to 2031.

Based on country, the Europe aesthetic medical devices market is categorized into Germany, the UK, France, Italy, Spain, Russia, Poland, Switzerland, Belgium, Netherlands, Luxembourg, Portugal, and the Rest of Europe. Our regional analysis states that Germany captured 21.8% share of Europe aesthetic medical devices market in 2023. It was assessed at US$ 1,308.55 million in 2023 and is likely to hit US$ 3,079.26 million by 2031, registering a CAGR of 11.3% during 2023–2031.

Key players operating in the Europe aesthetic medical devices market are Merz Pharma GmbH & Co KGaA; Bausch Health Companies Inc; Lumenis Be Ltd; Venus Concept Inc; Cutera Inc; Fotona; InMode; Cynosure; LLC; and Asclepion Laser Technologies GmbH, among others.

• In February 2021, Asclepion Laser Technologies successfully introduced the new nano laser range: The NanoStar Family. The NanoStar family includes three new q-switch laser systems in three separate devices. A ruby laser (694 nm), a Nd:YAG laser (1,064 nm + 532 nm) and a combined device with all of the mentioned wavelengths including the innovative mixed-technology, giving perfect conditions for every need. The family uses the well-known Q-qwitched technology, which allows for treatment of tattoos, pigments and others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com